title: Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.
authors.affiliation: Department of Urology, Medical University of Warsaw, Warsaw, Poland. Electronic address: slawomir.poletajew@wum.edu.pl.
authors.forename: Sławomir
authors.initials: S
authors.lastname: Poletajew
authors.affiliation: Department of Urology, Medical University of Warsaw, Warsaw, Poland.
authors.forename: Piotr
authors.initials: P
authors.lastname: Radziszewski
authors.affiliation: Department of Urology, Fundacio Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain.
authors.forename: Juan
authors.initials: J
authors.lastname: Palou
mesh_terms: D000276:Adjuvants, Immunologic; D000283:Administration, Intravesical; D001500:BCG Vaccine; D001407:Bacillus; D006801:Humans; D016685:Mitomycin; D001749:Urinary Bladder Neoplasms
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D016685:Mitomycin